Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; Achieves 2024 Financial Guidance

Go back to Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; Achieves 2024 Financial Guidance
IRONWOOD PHARMA-A (NASDAQ: IRWD) Delayed: 3.82 --0 (-0%)
Previous Close $3.82    52 Week High $16.89 
Open $3.82    52 Week Low $7.35 
Day High $3.82    P/E N/A 
Day Low $3.82    EPS $-2.35 
Volume 1,222